Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells

[1]  J. McCubrey,et al.  Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells. , 2000, Advances in enzyme regulation.

[2]  J. McCubrey,et al.  Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism , 2000, Leukemia.

[3]  J. McCubrey,et al.  A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells , 2000, Oncogene.

[4]  J. McCubrey,et al.  Serine/threonine phosphorylation in cytokine signal transduction , 2000, Leukemia.

[5]  J. McCubrey,et al.  Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs , 1999, Leukemia.

[6]  T. Ito,et al.  Ceramide Induces Bcl2 Dephosphorylation via a Mechanism Involving Mitochondrial PP2A* , 1999, The Journal of Biological Chemistry.

[7]  T. Fojo,et al.  Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells , 1999, Leukemia.

[8]  R. K Srivastava,et al.  Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Mumby,et al.  Reversible Phosphorylation of Bcl2 following Interleukin 3 or Bryostatin 1 Is Mediated by Direct Interaction with Protein Phosphatase 2A* , 1998, The Journal of Biological Chemistry.

[10]  R. Schmidt-Ullrich,et al.  The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity , 1998, Leukemia.

[11]  J. McCubrey,et al.  Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells , 1998, Leukemia.

[12]  W. May,et al.  A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis* , 1998, The Journal of Biological Chemistry.

[13]  M. Minden,et al.  Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid. , 1998, Blood.

[14]  M. Scheid,et al.  Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Korsmeyer,et al.  Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase , 1998, Molecular and Cellular Biology.

[16]  C. Croce,et al.  Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. , 1998, Cancer research.

[17]  M. David,et al.  Interferonγ Activation of Raf-1 Is Jak1-dependent and p21ras-independent* , 1998, The Journal of Biological Chemistry.

[18]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[19]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[20]  M. McMahon,et al.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.

[21]  G. Kroemer.  The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[22]  E. Petricoin,et al.  Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway , 1997, Molecular and cellular biology.

[23]  J. McCubrey,et al.  Regulation of interleukin 3 expression in normal and autocrine transformed hematopoietic cells (Review). , 1997, International journal of oncology.

[24]  P. Tsichlis,et al.  Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Lloyd,et al.  Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.

[26]  J. McCubrey,et al.  Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: effects of mutations that result in autocrine growth stimulation and malignant transformation. , 1997, Cytokines, cellular & molecular therapy.

[27]  K. Arai,et al.  Characterization of cis-acting sequences and trans-acting signals regulating early growth response 1 and c-fos promoters through the granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. , 1997, Blood.

[28]  K. Pumiglia,et al.  Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[30]  John Calvin Reed,et al.  Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria , 1996, Cell.

[31]  K. Sakamoto,et al.  The molecular mechanism of action of granulocyte-macrophage colony-stimulating factor. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[32]  H. Lee,et al.  Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321. , 1996, Blood.

[33]  S. Korsmeyer,et al.  Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.

[34]  John Calvin Reed,et al.  Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Lotem,et al.  Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. , 1996, Leukemia.

[36]  L. Neckers,et al.  Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. , 1996, Cancer research.

[37]  J. McCubrey,et al.  Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. , 1996, Leukemia.

[38]  P. Dent,et al.  Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation , 1996, Molecular and cellular biology.

[39]  K. Sakamoto,et al.  Granulocyte-Macrophage Colony-stimulating Factor Induces the Transcriptional Activation of egr-1 through a Protein Kinase A-independent Signaling Pathway (*) , 1995, The Journal of Biological Chemistry.

[40]  D. Morrison.  Mechanisms regulating Raf‐1 activity in signal transduction pathways , 1995, Molecular reproduction and development.

[41]  C. Pritchard,et al.  Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells , 1995, Molecular and cellular biology.

[42]  J C Reed,et al.  The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. , 1995, Oncogene.

[43]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Morrison,et al.  Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro , 1995, Molecular and cellular biology.

[45]  J. McCubrey,et al.  Differential-effects of viral and cellular oncogenes on the growth factor-dependency of hematopoietic-cells. , 1995, International journal of oncology.

[46]  K. Sakamoto,et al.  Transcriptional Activation of egr-1 by Granulocyte-Macrophage Colony-stimulating Factor but Not Interleukin 3 Requires Phosphorylation of cAMP Response Element-binding Protein (CREB) on Serine 133 (*) , 1995, The Journal of Biological Chemistry.

[47]  S. Korsmeyer,et al.  Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[48]  K. Arai,et al.  Suppression of apoptotic death in hematopoietic cells by signalling through the IL‐3/GM‐CSF receptors. , 1995, The EMBO journal.

[49]  R. Jove,et al.  Expression, purification and characterization of recombinant mitogen-activated protein kinase kinases. , 1994, The Biochemical journal.

[50]  S. Krajewski,et al.  Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. , 1994, Oncogene.

[51]  H. Lee,et al.  Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter , 1994, Molecular and cellular biology.

[52]  J. Cleveland,et al.  v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. , 1994, Oncogene.

[53]  B. Krippl,et al.  The E1A transcriptional control region is efficiently activated in proliferating tissues of transgenic mice. , 1994, Oncogene.

[54]  J. McCubrey,et al.  Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line. , 1994, Blood.

[55]  K. Sakamoto,et al.  Signal transduction by granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors. , 1994, Receptors & channels.

[56]  J. McCubrey,et al.  Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. , 1993, Oncogene.

[57]  K. Arai,et al.  Signal transduction by the high‐affinity GM‐CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. , 1993, The EMBO journal.

[58]  M. McMahon,et al.  Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase , 1993, Molecular and cellular biology.

[59]  P. Dent,et al.  Activation of the Mitogen-Activated Protein Kinase Pathway in Triton X-100 Disrupted NIH-3T3 Cells by p21 ras and In Vitro by Plasma Membranes from NIH 3T3 Cells , 2022 .

[60]  K. Arai,et al.  Cytokine receptors and signal transduction. , 2005, Annual review of immunology.

[61]  K. Arai,et al.  Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors , 1991, Cell.

[62]  S. Korsmeyer,et al.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[63]  M. Carroll,et al.  Role of raf-1 protein kinase in IL-3 and GM-CSF-mediated signal transduction. , 1990, Current topics in microbiology and immunology.

[64]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[65]  J. McCubrey,et al.  Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms. , 1989, Oncogene research.

[66]  A. Miller,et al.  Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.

[67]  J. McCubrey,et al.  Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[68]  E. Scolnick,et al.  Growth of factor-dependent hemopoietic precursor cell lines , 1980, The Journal of experimental medicine.